David Esq - Trxade Inhouse Counsel

MEDS Stock  USD 6.01  0.03  0.50%   

Executive

David Esq is Inhouse Counsel of Trxade Group
Address 2420 Brunello Trace, Lutz, FL, United States, 33558
Phone800 261 0281
Webhttps://www.trxadehealth.com

Trxade Management Efficiency

The company has return on total asset (ROA) of (0.559) % which means that it has lost $0.559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (30.9992) %, meaning that it created substantial loss on money invested by shareholders. Trxade's management efficiency ratios could be used to measure how well Trxade manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -5.25 in 2024. Return On Capital Employed is likely to gain to -7.07 in 2024. At this time, Trxade's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 10.3 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 10 K in 2024.
The company currently holds 7.1 M in liabilities with Debt to Equity (D/E) ratio of 0.93, which is about average as compared to similar companies. Trxade Group has a current ratio of 1.29, suggesting that it may not be capable to disburse its financial obligations when due. Debt can assist Trxade until it has trouble settling it off, either with new capital or with free cash flow. So, Trxade's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Trxade Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Trxade to invest in growth at high rates of return. When we think about Trxade's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

EXECUTIVE Age

Theresa MotaSunLink Health Systems
N/A
James MulliganSunLink Health Systems
102
Xiaoping WangBimi International Medical
43
Nicole SanchezLeafly Holdings
N/A
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people. Trxade Group (MEDS) is traded on NASDAQ Exchange in USA. It is located in 2420 Brunello Trace, Lutz, FL, United States, 33558 and employs 8 people. Trxade is listed under Consumer Staples Distribution & Retail category by Fama And French industry classification.

Management Performance

Trxade Group Leadership Team

Elected by the shareholders, the Trxade's board of directors comprises two types of representatives: Trxade inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Trxade. The board's role is to monitor Trxade's management team and ensure that shareholders' interests are well served. Trxade's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Trxade's outside directors are responsible for providing unbiased perspectives on the board's policies.
Prashant Patel, President, Founder
David Saslow, Inhouse Counsel
Surendra Ajjarapu, Chairman, Founder
Prashant RPh, President Founder
Jariel Morales, Executive President
Shafaat PharmD, LLC Solutions
Janet Huffman, Principal CFO
David Esq, Inhouse Counsel
Ramesh Kenchappa, Chief Officer

Trxade Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Trxade a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Trxade in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Trxade's short interest history, or implied volatility extrapolated from Trxade options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Trxade Group is a strong investment it is important to analyze Trxade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Trxade's future performance. For an informed investment choice regarding Trxade Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Trxade Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Trxade Group information on this page should be used as a complementary analysis to other Trxade's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Trxade Stock analysis

When running Trxade's price analysis, check to measure Trxade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trxade is operating at the current time. Most of Trxade's value examination focuses on studying past and present price action to predict the probability of Trxade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trxade's price. Additionally, you may evaluate how the addition of Trxade to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Trxade's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trxade. If investors know Trxade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trxade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.766
Earnings Share
(17.96)
Revenue Per Share
10.827
Quarterly Revenue Growth
0.043
Return On Assets
(0.56)
The market value of Trxade Group is measured differently than its book value, which is the value of Trxade that is recorded on the company's balance sheet. Investors also form their own opinion of Trxade's value that differs from its market value or its book value, called intrinsic value, which is Trxade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trxade's market value can be influenced by many factors that don't directly affect Trxade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trxade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trxade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trxade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.